Registration

W STRATEGIES, LLC for STOKE THERAPEUTICS

Firm
Client
Income
—
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Education around innovation in neurological rare disease.

LobbyistCovered position, as disclosed
DARREN WILLCOX New Asst. for Policy, Speaker Dennis Hastert; Admin. Asst., Legislative Director, Legislative Asst., Cong. Porter Goss; House Rules Comm. Assoc., Subcommittee Staff Director

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
MONTRAGO TRUSTEES LIMITED Cyprus Cyprus 39.0% —
EZBON INTERNATIONAL LIMITED British Virgin Islands British Virgin Islands 20.0% —
SKORPIOS TRUST Cyprus Cyprus 39.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.